Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Intellia Therapeutics (NTLA) PT Raised to $130 at Chardan Capital Markets
-
Intellia Therapeutics (NTLA) PT Raised to $85 at Chardan Capital Markets
-
Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Pre-Open Movers 05/15: (XENE) (PFNX) (SORL) Higher; (VIPS) (MYE) (TSLA) Lower (more...)
-
UPDATE: Chardan Capital Markets Upgrades Intellia Therapeutics (NTLA) to Buy
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Pre-Open Movers 08/29: (MOV) (CTLT) (IMGN) Higher; (FINL) (ACOR) (JILL) Lower (more...)
-
Chardan Capital Markets Downgrades Intellia Therapeutics (NTLA) to Neutral
-
Intellia Therapeutics (NTLA): Raising PT - Chardan
-
Chardan Capital Markets Starts Intellia Therapeutics (NTLA) at Buy

